Following the success of the HealthTech Investment Forum in Basel, we are happy to announce the European HealthTech CEO Forum, which will take place on the 18th of February at Hilton Zurich Airport Hotel, just a day before our European Life Sciences CEO Forum. We anticipate over 200 delegates, covering innovation in the digital health and medtech and devices sectors, with the target audience being corporate and financial investors/partners and advisors. The programme will feature topical keynotes and panels with industry leaders and over 20 corporate presentations by public, private and growth companies, and 20+ pitches by seed companies. Networking is supported by the online One-2-One meeting system which allows for pre-arranged meetings at the dedicated meeting facilities.
Plenary Sessions will Include:
Future Vision of HealthTech & Partnering with Strategics Panel
MedTech & Device Innovation Panel
Cloud Computing in HealthTech Panel
Cutting Edge Tech Panel:
Personalised Health & Diagnostics
Israeli Innovators Panel
Rising Stars Seed Session
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
Make connections, engage in conversation, and exchange knowledge with key decision-makers eager to learn how your company can help them meet their goals and achieve their mission. Exhibiting at the European HealthTech CEO Forum is an effective way to gain leads, introduce new products and services, expand sales, and build relationships. Exhibition space is very limited - express your interest to secure the area.
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market. Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting, exhibition or sponsorship opportunities, please contact: Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
FINANCIAL, ADVISORY, INVESTORS AT 7th HTIF:
Accequa AB Acme Investments SPF Sarl ACXIT Capital Management GmbH Additio Investment Group Additio Investment Group Advent France Biotechnology aescuvest international GmbH Agile Capital Markets Aglaia BioMedical Ventures Alta Life Sciences ANDERA Partners Arrowfield Capital Ascend Capital, LLC Asklepios Advisors Banque Profil de Gestion SA BaselArea.swiss Bavarian Capital Management Bergmann zur Hausen & Cie. GmbH BERNINA BioInvest Ltd Bio Capital Impact Fund Bio Medi Gene Ventures BioGeneration Ventures BioMedPartners AG BioStart Consulting GmbH Biotech Alliances International, Inc. Boehringer Ingelheim Venture Fund GmbH BOHE Angel Fund Bootstrap Europe Breslin AG BROTHERS & PARTNERS EUROPE C.P. Medical Consulting Capital Grand Est Capricorn Partners NV Capricorn Venture Partners CBC Group (C-Bridge Capital) Cederberg GmbH ChinaBio Group CoFeS China Ltd. Convergence Partners AG Coulter Partners Cukierman & Co. Life Sciences